Chune Yu
Impact in
-
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 2
- Cancer-related Molecular Pathways 2
- Cancer Cells and Metastasis 2
-
- Melanoma and MAPK Pathways 4
- Co-authors
- Hubing Shi (8 shared papers)Jiqiao Yang (6 shared papers)Xiaobo Zheng (8 shared papers)Xuelei Ma (5 shared papers)Xiaowei Liu (5 shared papers)Jing Yu (8 shared papers)Mingqing Xu (5 shared papers)Min Zhang (2 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Aging (2 papers)Scientific Reports (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Cell Cycle (1 paper)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Chune Yu
13 papers receiving 411 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 117
- Oncology 181
- Immunology 90
- Molecular Biology 236
- Immunology and Allergy 14
Countries citing papers authored by Chune Yu
This map shows the geographic impact of Chune Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chune Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chune Yu more than expected).
Fields of papers citing papers by Chune Yu
This network shows the impact of papers produced by Chune Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chune Yu. The network helps show where Chune Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chune Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 89 | |
| 2 | 2020 | 66 | |
| 3 | 2021 | 52 | |
| 4 | 2022 | 47 | |
| 5 | 2021 | 46 | |
| 6 | 2019 | 33 | |
| 7 | 2020 | 23 | |
| 8 | 2021 | 17 | |
| 9 | 2021 | 15 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 1 | |
| 14 | 2026 | 0 | |
| 15 | 2025 | 0 |
About Chune Yu
Chune Yu is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Allergy and Immunology, having authored 15 papers that have together received 413 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cell Adhesion Molecules Research (3 papers), Immunotherapy and Immune Responses (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (117 citations), Oncology (181 citations), Immunology (90 citations), Molecular Biology (236 citations) and Immunology and Allergy (14 citations). Chune Yu has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Hubing Shi, Jiqiao Yang, Xiaobo Zheng, Xuelei Ma, Xiaowei Liu, Jing Yu, Mingqing Xu, Min Zhang, Hongyu Jin and Ya Luo. Their work appears in journals such as Frontiers in Oncology, Aging, Scientific Reports, Frontiers in Cell and Developmental Biology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.